The Possible Role of Matrix Metalloprotienase-2 in the Relapse in Patients with Stage II Colon Cancer Treated by Curative Surgery.
Nigel P MurrayRicardo VillalonSocrates AedoDan HartmannPatricia Maria RodriguezPublished in: Asian Pacific journal of cancer prevention : APJCP (2023)
Patients with stable ALCs did not relapse; decreasing ALCs were associated with increasing MMP-2 scores, the appearance of CTCs and relapse.